Bayer’s postmarket study of Essure is back on track after a sharp drop in participants in October 2022, the US Food and Drug Administration said in a three-year interim update.
Essure, a sterilization implant marketed by Bayer, was recalled in 2018 in the US. By the end of 2019, all unused devices were removed from the market. (Also see "
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?